Published in Ann Surg Oncol on December 01, 2009
MET amplification identifies a small and aggressive subgroup of esophagogastric adenocarcinoma with evidence of responsiveness to crizotinib. J Clin Oncol (2011) 3.27
Epidemiology of esophageal cancer. World J Gastroenterol (2013) 3.01
Adenocarcinoma of the esophagogastric junction: incidence, characteristics, and treatment strategies. Gastric Cancer (2010) 1.36
Factors predicting survival in patients with proximal gastric carcinoma involving the esophagus. World J Gastroenterol (2012) 1.05
The optimal extent of lymph node dissection for adenocarcinoma of the esophagogastric junction differs between Siewert type II and Siewert type III patients. Gastric Cancer (2014) 0.89
Pattern of abdominal nodal spread and optimal abdominal lymphadenectomy for advanced Siewert type II adenocarcinoma of the cardia: results of a multicenter study. Gastric Cancer (2012) 0.87
Adenocarcinomas of the esophagogastric junction: experiences at a single institution in China. World J Surg Oncol (2013) 0.81
Comparison of the surgical treatment strategies for Siewert type II squamous cell carcinoma in the same area as esophagogastric junction carcinoma: data from a single Japanese high-volume cancer center. Surg Today (2013) 0.81
Adenocarcinoma of esophagogastric junction. Chin J Cancer Res (2014) 0.80
Ratio of metastatic to examined lymph nodes, a helpful staging system and independent prognostic factor of esophagogastric junction cancer. PLoS One (2013) 0.79
Overexpression of YWHAZ as an independent prognostic factor in adenocarcinoma of the esophago-gastric junction. Am J Cancer Res (2016) 0.79
Clinicopathological characterisation of small (2 cm or less) proximal and distal gastric carcinomas in a Chinese population. Pathology (2015) 0.78
Carcinoma of the gastroesophageal junction in Chinese patients. World J Gastroenterol (2012) 0.77
Lymph node metastasis in gastric cardiac adenocarcinoma in male patients. World J Gastroenterol (2013) 0.75
Should Splenic Hilar Lymph Nodes be Dissected for Siewert Type II and III Esophagogastric Junction Carcinoma Based on Tumor Diameter?: A Retrospective Database Analysis. Medicine (Baltimore) (2016) 0.75
The prognostic value of preoperative inflammation-based prognostic scores and nutritional status for overall survival in resected patients with nonmetastatic Siewert type II/III adenocarcinoma of esophagogastric junction. Medicine (Baltimore) (2017) 0.75
Superior survival with capecitabine plus docetaxel combination therapy in anthracycline-pretreated patients with advanced breast cancer: phase III trial results. J Clin Oncol (2002) 4.47
Nodal dissection for patients with gastric cancer: a randomised controlled trial. Lancet Oncol (2006) 4.38
Risk factors for early and late recurrence in hepatitis B-related hepatocellular carcinoma. J Hepatol (2009) 2.56
The prognostic value of the number of negative lymph nodes in esophageal cancer patients after transthoracic resection. Ann Thorac Surg (2013) 2.14
Retracted Aberrant methylation of Reprimo in human malignancies. Int J Cancer (2005) 2.13
miR-21 microRNA expression in human gastric carcinomas and its clinical association. Anticancer Res (2008) 2.09
Prognostic significance of vascular endothelial growth factor, basic fibroblast growth factor, and angiogenin in patients with resectable hepatocellular carcinoma after surgery. Ann Surg Oncol (2003) 2.08
Mitochondrial DNA mutations and mitochondrial DNA depletion in gastric cancer. Genes Chromosomes Cancer (2005) 1.99
Mitochondrial genome instability and mtDNA depletion in human cancers. Ann N Y Acad Sci (2005) 1.97
Biochemical predictors for absence of common bile duct stones in patients undergoing laparoscopic cholecystectomy. Surg Endosc (2007) 1.91
Prognostic variables in thoracic esophageal squamous cell carcinoma. Ann Thorac Surg (2009) 1.81
Mitochondrial DNA mutations and mitochondrial DNA depletion in breast cancer. Genes Chromosomes Cancer (2006) 1.77
Non-Hodgkin's lymphoma presenting as a large chest wall mass. Ann Thorac Surg (2006) 1.77
Epigenetic regulation of miR-34b and miR-129 expression in gastric cancer. Int J Cancer (2011) 1.68
Surgical results of synchronous multiple primary lung cancers: similar to the stage-matched solitary primary lung cancers? Ann Thorac Surg (2013) 1.64
Differential mechanism and prognostic impact of diabetes mellitus on patients with hepatocellular carcinoma undergoing surgical and nonsurgical treatment. Am J Gastroenterol (2004) 1.63
The activated Notch1 signal pathway is associated with gastric cancer progression through cyclooxygenase-2. Cancer Res (2009) 1.62
Small cell carcinoma of the esophagus: a report of 16 cases from a single institution and literature review. Ann Thorac Surg (2011) 1.62
Open versus thoracoscopic esophagectomy in patients with esophageal squamous cell carcinoma. World J Surg (2014) 1.53
A reappraisal of surgical management for squamous cell carcinoma in the pharyngoesophageal junction. J Surg Oncol (2006) 1.53
Retracted Evidence for the early involvement of interleukin 17 in human and experimental renal allograft rejection. J Pathol (2002) 1.52
Temsirolimus enhances the efficacy of cetuximab in colon cancer through a CIP2A-dependent mechanism. J Cancer Res Clin Oncol (2014) 1.49
Pulmonary metastasectomy for hepatocellular carcinoma. J Chin Med Assoc (2004) 1.46
Antisense thymidylate synthase electrogene transfer to increase uptake of radiolabeled iododeoxyuridine in a murine model. J Nucl Med (2004) 1.43
Selecting a short-term prognostic model for hepatocellular carcinoma: comparison between the model for end-stage liver disease (MELD), MELD-sodium, and five cancer staging systems. J Clin Gastroenterol (2009) 1.42
Clinical significance of AXL kinase family in gastric cancer. Anticancer Res (2002) 1.40
Comparison of the 6th and 7th editions of the American Joint Committee on Cancer tumor-node-metastasis staging system in patients with resected esophageal carcinoma. Ann Thorac Surg (2010) 1.38
Long-term results of anti-Helicobacter pylori therapy in early-stage gastric high-grade transformed MALT lymphoma. J Natl Cancer Inst (2005) 1.35
Incidence and factors associated with recurrence patterns after intended curative surgery for gastric cancer. World J Surg (2003) 1.35
Effect of formalin fixation on tumor size determination in stage I non-small cell lung cancer. Ann Thorac Surg (2007) 1.34
A comparison of prognosis between patients with hepatitis B and C virus-related hepatocellular carcinoma undergoing resection surgery. World J Surg (2011) 1.29
Aberrant hypermethylation of miR-9 genes in gastric cancer. Epigenetics (2011) 1.29
Factors affecting recurrence in node-negative advanced gastric cancer. J Gastroenterol Hepatol (2009) 1.26
Does drainage fluid amylase reflect pancreatic leakage after pancreaticoduodenectomy? World J Surg (2003) 1.25
Preoperative serum albumin level is a prognostic indicator for adenocarcinoma of the gastric cardia. J Gastrointest Surg (2004) 1.24
Primary thymic carcinoma. Ann Thorac Surg (2002) 1.23
Epigenetic regulation of miR-196b expression in gastric cancer. Genes Chromosomes Cancer (2010) 1.23
Irritable bowel syndrome and negative appendectomy: a prospective multivariable investigation. Gut (2007) 1.23
Glycine N-methyltransferase-/- mice develop chronic hepatitis and glycogen storage disease in the liver. Hepatology (2007) 1.23
Sleep duration and all-cause mortality: a critical review of measurement and associations. Ann Epidemiol (2013) 1.23
The -251T allele of the interleukin-8 promoter is associated with increased risk of gastric carcinoma featuring diffuse-type histopathology in Chinese population. Clin Cancer Res (2005) 1.22
Prognostic value and clinical relevance of the 6th Edition 2002 American Joint Committee on Cancer staging system in patients with resectable hepatocellular carcinoma. J Am Coll Surg (2006) 1.20
Analysis of the seventh edition of American Joint Committee on colon cancer staging. Int J Colorectal Dis (2011) 1.17
Expression of beta-F1-ATPase and mitochondrial transcription factor A and the change in mitochondrial DNA content in colorectal cancer: clinical data analysis and evidence from an in vitro study. Int J Colorectal Dis (2008) 1.16
Relationship between genetic alterations and prognosis in sporadic colorectal cancer. Int J Cancer (2006) 1.16
Pulmonary hamartoma. J Chin Med Assoc (2004) 1.16
Long-term results of pathological stage I non-small cell lung cancer: validation of using the number of totally removed lymph nodes as a staging control. Eur J Cardiothorac Surg (2003) 1.15
Peritoneal carcinomatosis and lymph node metastasis are prognostic indicators in patients with Borrmann type IV gastric carcinoma. Hepatogastroenterology (2002) 1.15
Interval appendectomy after conservative treatment of an appendiceal mass. World J Surg (2006) 1.13
Is thymectomy necessary in nonmyasthenic patients with early thymoma? J Thorac Oncol (2013) 1.12
Tumor length as a prognostic factor in esophageal squamous cell carcinoma. Ann Thorac Surg (2011) 1.12
Biological effect of far-infrared therapy on increasing skin microcirculation in rats. Photodermatol Photoimmunol Photomed (2006) 1.11
Comparison of the survival difference between AJCC 6th and 7th editions for gastric cancer patients. World J Surg (2011) 1.11
Functional assessment of human alcohol dehydrogenase family in ethanol metabolism: significance of first-pass metabolism. Alcohol Clin Exp Res (2006) 1.10
Early postoperative CEA level is a better prognostic indicator than is preoperative CEA level in predicting prognosis of patients with curable colorectal cancer. Int J Colorectal Dis (2011) 1.09
Initial experience of robotic gastrectomy and comparison with open and laparoscopic gastrectomy for gastric cancer. J Gastrointest Surg (2012) 1.08
Thrombocytosis: a paraneoplastic syndrome in patients with hepatocellular carcinoma. World J Gastroenterol (2004) 1.08
The proportion of 3 classes of lateral throat form. Int J Prosthodont (2007) 1.07
Notch2-induced COX-2 expression enhancing gastric cancer progression. Mol Carcinog (2011) 1.07
Mucoepidermoid tumors of the lung: analysis of 11 cases. J Chin Med Assoc (2004) 1.06
Long-term results of hepatic resection for hepatocellular carcinoma originating from the noncirrhotic liver. Arch Surg (2004) 1.06
Comparison of recurrence after hepatic resection in patients with hepatitis B vs. hepatitis C-related small hepatocellular carcinoma in hepatitis B virus endemic area. Liver Int (2005) 1.06
The role of mitochondrial DNA alterations in esophageal squamous cell carcinomas. J Thorac Cardiovasc Surg (2009) 1.05
Hepatic resection can provide long-term survival of patients with non-early-stage hepatocellular carcinoma: extending the indication for resection? Surgery (2012) 1.04
Rho/Rhotekin-mediated NF-kappaB activation confers resistance to apoptosis. Oncogene (2004) 1.04
CIP2A is a predictor of poor prognosis in colon cancer. J Gastrointest Surg (2012) 1.03
Complications following D3 gastrectomy: post hoc analysis of a randomized trial. World J Surg (2006) 1.03
SOCS6, down-regulated in gastric cancer, inhibits cell proliferation and colony formation. Cancer Lett (2009) 1.02
Multiple primary cancers in patients with gastric cancer. Hepatogastroenterology (2006) 1.02
Management of primary chest wall tumors: 14 years' clinical experience. J Chin Med Assoc (2006) 1.02
IL-6 enriched lung cancer stem-like cell population by inhibition of cell cycle regulators via DNMT1 upregulation. Int J Cancer (2014) 1.02